IITRI is a well-established provider of preclinical vaccine development services to government and commercial sponsors, with extensive experience evaluating the efficacy and safety of vaccines against viral and bacterial pathogens. We also provide BSL-2 toxicology, safety, and immunogenicity studies for the development of cancer vaccine immunotherapies.
We offer comprehensive preclinical programs from our single location in Chicago to provide scientific expertise to move your development program forward. Services include BSL-2/3 in vivo challenge studies, GLP safety and toxicology programs to support IND and NDA submissions, bioanalytical analysis of human clinical trial samples, and Animal Rule studies. Routes of administration include injection, inhalation, intranasal and electroporation-mediated delivery.
We also offer vaccine potency testing in a GMP environment for vaccine stability studies or manufacturing batch testing purposes.